BridgeBio Pharma, Inc. (BBIO)
68.14
-2.58
(-3.65%)
USD |
NASDAQ |
Feb 20, 16:00
68.70
+0.56
(+0.82%)
After-Hours: 20:00
BridgeBio Pharma EPS Diluted (Quarterly) : -0.9525 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Insmed, Inc. | -1.538 |
| Mirum Pharmaceuticals, Inc. | 0.051 |
| Cogent Biosciences, Inc. | -0.6934 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Sarepta Therapeutics, Inc. | -1.795 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -184.94M |
| Revenue (Quarterly) | 120.70M |
| Total Expenses (Quarterly) | 303.44M |
| Enterprise Value | 15.13B |
| Gross Profit Margin (Quarterly) | 93.98% |
| Profit Margin (Quarterly) | -153.2% |
| Earnings Yield | -6.14% |
| Normalized Earnings Yield | -6.010 |